中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
17期
80-81
,共2页
益胃散%幽门螺杆菌%胃病
益胃散%幽門螺桿菌%胃病
익위산%유문라간균%위병
Yiwei San%Helicobacter pylori%Gastric diseases
目的:探究益胃散治疗幽门螺杆菌相关胃病的临床效果。方法:将我院收治的68例幽门螺杆菌阳性胃病患者作为研究对象,按照随机分组方式将患者分为观察组(34例)和对照组(34例),观察组使用益胃散治疗,对照组给予西药三联方法治疗,对患者治疗前后的临床症状量表进行测评,分析治疗效果。结果:治疗后两组患者症状量表积分均有所降低,相比治疗前具有统计学意义(P<0.05),治疗后两组患者的症状积分和量表总积分对比均有显著差异(P<0.05);观察组治愈11例,显效15例,好转7例,无效1例,综合有效率(治愈+显效+有效)为97.06%,对照组治愈8例,显效11例,好转7例,无效8例,综合有效率为76.47%,两组患者综合有效率对比具有显著的统计学差异(P<0.05)。结论:益胃散治疗幽门螺杆菌相关胃病具有良好的效果,值得在临床中推广。
目的:探究益胃散治療幽門螺桿菌相關胃病的臨床效果。方法:將我院收治的68例幽門螺桿菌暘性胃病患者作為研究對象,按照隨機分組方式將患者分為觀察組(34例)和對照組(34例),觀察組使用益胃散治療,對照組給予西藥三聯方法治療,對患者治療前後的臨床癥狀量錶進行測評,分析治療效果。結果:治療後兩組患者癥狀量錶積分均有所降低,相比治療前具有統計學意義(P<0.05),治療後兩組患者的癥狀積分和量錶總積分對比均有顯著差異(P<0.05);觀察組治愈11例,顯效15例,好轉7例,無效1例,綜閤有效率(治愈+顯效+有效)為97.06%,對照組治愈8例,顯效11例,好轉7例,無效8例,綜閤有效率為76.47%,兩組患者綜閤有效率對比具有顯著的統計學差異(P<0.05)。結論:益胃散治療幽門螺桿菌相關胃病具有良好的效果,值得在臨床中推廣。
목적:탐구익위산치료유문라간균상관위병적림상효과。방법:장아원수치적68례유문라간균양성위병환자작위연구대상,안조수궤분조방식장환자분위관찰조(34례)화대조조(34례),관찰조사용익위산치료,대조조급여서약삼련방법치료,대환자치료전후적림상증상량표진행측평,분석치료효과。결과:치료후량조환자증상량표적분균유소강저,상비치료전구유통계학의의(P<0.05),치료후량조환자적증상적분화량표총적분대비균유현저차이(P<0.05);관찰조치유11례,현효15례,호전7례,무효1례,종합유효솔(치유+현효+유효)위97.06%,대조조치유8례,현효11례,호전7례,무효8례,종합유효솔위76.47%,량조환자종합유효솔대비구유현저적통계학차이(P<0.05)。결론:익위산치료유문라간균상관위병구유량호적효과,치득재림상중추엄。
Objective: To explore the clinical effect of Yiwei San treatment of Helicobacter pylori associated gastric diseases. Methods:68 patients with positive Helicobacter pylori gastritis patients in our hospital as the research object, according to the randomized grouping clinical symptom of patients before and after the table for evaluation, analysis of therapeutic effect. Results:After treatment, two groups of patients with symptom scale scores were lower than before treatment, with statistical significance (P<0.05), the two groups after treatment in patients with symptoms and the scale total score comparison had significant difference (P<0.05). Two groups of patients, comprehensive efficiency compared with significant statistical difference (P<0.05). Conclusion: Yiwei San had a good effect of the treatment of Helicobacter pylori associated gastric diseases.